Deferox 500 mg (Tablet)
Unit Price: ৳ 120.00 (4 x 6: ৳ 2,880.00)
Strip Price: ৳ 720.00
Medicine Details
Category | Details |
---|---|
Generic | Deferasirox |
Company | Beacon pharmaceuticals plc |
Also available as |
Indications
- Treatment of chronic iron overload
- Repetitive blood transfusions
- Thalassaemia
- Sickle cell disease
- Myelodysplastic syndrome
- Non-transfusion-dependent thalassemia syndromes
Pharmacology
- Orally active chelator
- Highly selective for iron
- Tridentate ligand
- Excretion of iron in faeces
- Low affinity for zinc and copper
- Iron balance metabolic study
Dosage
- Initial daily dose of 20-40 mg/kg body weight
- Serum ferritin monitoring
- Dose adjustment based on trends in serum ferritin
- Dispersion in water or fruit juice
- Empty stomach administration
Administration
- Once daily on an empty stomach
- Dispersion in water or fruit juice
- Restrictions on consuming carbonated drinks or milk
Interaction
- Avoidance with aluminium-containing antacids
- Caution with drugs metabolized through CYP3A4
- Dose adjustments with specific drugs
- Caution with drugs having ulcerogenic potential
- Interaction with anticoagulants
Contraindications
- Hypersensitivity to active substance or excipients
- Creatinine clearance less than 40 ml/min
- Serum creatinine >2 times upper limit of normal
Side Effects
- Cytopenias
- Gastrointestinal discomfort
- Headache and dizziness
- Elevation of hepatic transaminases
- Rare cases of Stevens-Johnson syndrome and skin rash
- Auditory and ocular disturbances
Pregnancy & Lactation
- Pregnancy Category C
- No adequate and well-controlled studies in pregnant women
- Caution in use during pregnancy and lactation
- Unknown excretion in human milk
- Potential risk to the fetus
Precautions & Warnings
- Gastrointestinal bleeding, ulceration, and irritation
- Cytopenias monitoring
- Hypersensitivity reactions
- Use caution in combination with drugs having ulcerogenic or hemorrhagic potential
Use in Special Populations
- Pediatric use similar to adults
- Elderly patients at increased risk
- No studies in renal impairment or hepatic impairment
Overdose Effects
- Maximal dose of 40 mg/kg body weight
- No information on overdose effects
Therapeutic Class
- Antidote preparations
Storage Conditions
- Store below 25°C
- Protect from light
- Keep out of reach of children
Related Brands
- Asunra 100 mg (Dispersible Tablet) - novartis-bangladesh-ltd
- Asunra 400 mg (Dispersible Tablet) - novartis-bangladesh-ltd
- Ferasirrox 250 mg (Dispersible Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Desirox 250 mg (Dispersible Tablet) - cipla-limited
- Desirox 500 mg (Dispersible Tablet) - cipla-limited